Re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149–56

Castration Resistant ◽

Reply to Julie Steinestel, Christof Bernemann, Andres J. Schrader, and Jochen K. Lennerz's Letter to the Editor re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149–56. AR-V7 Testing: What's in it for the Patient?

European Urology ◽

10.1016/j.eururo.2017.06.032 ◽

2017 ◽

Vol 72 (6) ◽

pp. e170-e171 ◽

Cited By ~ 1

Author(s):

Jun Luo ◽

Brandon Luber ◽

Hao Wang ◽

Emmanuel S. Antonarakis

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Clin Oncol ◽

Tumor Cells ◽

Clinical Significance ◽

Splice Variant ◽

Second Line ◽

Castration Resistant ◽

Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer

JAMA Oncology ◽

10.1001/jamaoncol.2018.1621 ◽

2018 ◽

Vol 4 (9) ◽

pp. 1179 ◽

Cited By ~ 92

Author(s):

Howard I. Scher ◽

Ryon P. Graf ◽

Nicole A. Schreiber ◽

Anuradha Jayaram ◽

Eric Winquist ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Splice Variant ◽

Predictive Biomarker ◽

Castration Resistant ◽

The association between androgen receptor splice variant 7 status and prognosis of metastatic castration‐resistant prostate cancer: A systematic review and meta‑analysis

Andrologia ◽

10.1111/and.13642 ◽

2020 ◽

Vol 52 (7) ◽

Author(s):

Jiatong Zhou ◽

Ranlu Liu

Keyword(s):

Prostate Cancer ◽

Systematic Review ◽

Androgen Receptor ◽

Splice Variant ◽

Meta Analysis ◽

Castration Resistant ◽

Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2019.04.006 ◽

2019 ◽

Vol 76 (5) ◽

pp. 676-685 ◽

Cited By ~ 22

Author(s):

Adam Sharp ◽

Jon C. Welti ◽

Maryou B.K. Lambros ◽

David Dolling ◽

Daniel Nava Rodrigues ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumour Cell ◽

Splice Variant ◽

Clinical Utility ◽

Castration Resistant ◽

Circulating Tumour Cell ◽

Abstract 2148: Exploitation of androgen receptor splice variant signaling by guanine nucleotide exchange factor Vav3 in castration resistant prostate cancer

10.1158/1538-7445.am2012-2148 ◽

2012 ◽

Cited By ~ 1

Author(s):

Stephanie Peacock ◽

Cale Fahrenholtz ◽

Kerry L. Burnstein

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Splice Variant ◽

Guanine Nucleotide ◽

Nucleotide Exchange ◽

Guanine Nucleotide Exchange ◽

Castration Resistant ◽

Nucleotide Exchange Factor ◽

Abstract 2910: Androgen receptor splice variant-7 predicts resistance to enzalutamide in patients with castration-resistant prostate cancer

10.1158/1538-7445.am2014-2910 ◽

2014 ◽

Cited By ~ 1

Author(s):

Emmanuel S. Antonarakis ◽

Changxue Lu ◽

Hao Wang ◽

Brandon Luber ◽

Mary Nakazawa ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Splice Variant ◽

Castration Resistant ◽

Use of nuclear-localized androgen receptor splice variant 7 protein in CTCs after 1st androgen receptor signaling inhibitor (ARSi) as a predictive biomarker for overall survival on a second ARSi or taxane chemotherapy in metastatic castration-resistant prostate cancer (mCRPC)

Annals of Oncology ◽

10.1093/annonc/mdy284.045 ◽

2018 ◽

Vol 29 ◽

pp. viii292-viii293

Author(s):

H.I. Scher ◽

R.P. Graf ◽

M. Hulling ◽

E. Carbone ◽

R. Dittamore

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Androgen Receptor ◽

Splice Variant ◽

Predictive Biomarker ◽

Androgen Receptor Signaling ◽

Castration Resistant ◽

Androgen Receptor Splice Variant ◽

Taxane Chemotherapy

Androgen receptor splice variant, AR-V7, and resistance to enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.5001 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5001-5001 ◽

Cited By ~ 10

Author(s):

Emmanuel S. Antonarakis ◽

Changxue Lu ◽

Hao Wang ◽

Brandon Luber ◽

Mary Nakazawa ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Splice Variant ◽

Castration Resistant ◽

Androgen receptor (AR) activation levels on circulating tumor cells (CTCs) to predict response to second-line therapy in castration-resistant prostate cancer (CRPC)

Science-Business eXchange ◽

10.1038/scibx.2012.1168 ◽

2012 ◽

Vol 5 (44) ◽

pp. 1168-1168

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Second Line ◽

Second Line Therapy ◽

Castration Resistant ◽

Line Therapy

Current status of circulating tumor cell androgen receptor splice variant-7 in metastatic castration-resistant prostate cancer

Annals of Translational Medicine ◽

10.21037/atm.2019.12.137 ◽

2019 ◽

Vol 0 ◽

pp. S375-S375

Author(s):

Shinichi Sakamoto

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cell ◽

Splice Variant ◽

Circulating Tumor Cell ◽

Current Status ◽

Castration Resistant ◽